Use of isothiocyanate compounds
AssigneeJc (Wuxi) Company, Inc.
InventorsJingcai Cheng, Chunxia Zhang, Zhiwei Cheng
Life of this patent
Estimating the term…
Abstract
Disclosed is the use of isothiocyanate compounds. In particular, disclosed is the use of a compound as shown by Formula (I) or a derivative as shown by Formula (II) in the manufacture of a composition or preparation for preventing and/or treating hyperlipidemia. The compound of the present invention can reduce the levels of triglycerides and low density lipoproteins in the serum of mammals (such as rats and humans), increase the level of high density lipoproteins in the serum, and reduce the level of total bilirubin in the serum of mammals (such as rats and humans).
Claims9
A method of preventing and/or treating hyperbilirubinemia, comprising administering a compound to a mammal in need thereof,
- wherein the compound is phenylethyl isothiocyanate, the hyperbilirubinemia is selected from the group consisting of:
- hemolytic jaundice, hepatic jaundice, cholestasis, gilbert syndrome, and a combination thereof.
Dependencies are inferred from the claim text.